Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A position paper of the International Lipid Expert Panel

Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A position paper of the International Lipid Expert Panel

The risk of atherosclerotic cardiovascular disease (ASCVD) is strongly related to lifetime exposure to low-density lipoprotein (LDL)-cholesterol in longitudinal studies. Lipid-lowering therapy (using statins, ezetimibe and PCSK9 inhibitors) substantially ameliorates the risk and is associated with l...

Full description

Bibliographic Details
Main Authors: Maciej Banach, Alberico L. Catapano, Arrigo F.G. Cicero, Carlos Escobar, Bernhard Foger, Niki Katsiki, Gustavs Latkovskis, Michal Rakowski, Zeljko Reiner, Amirhossein Sahebkar, Geeta Sikand, Peter E. Penson, on behalf of the International Lipid Expert Panel (ILEP)
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Pharmacological Research
Subjects:
Monacolin
Red Yeast Rice
Cardiovascular risk
Risk stratification
No-statin therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661822003152

Internet

http://www.sciencedirect.com/science/article/pii/S1043661822003152

Similar Items